Vontobel Holding’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,647
Closed -$62.1K 1134
2024
Q4
$62.1K Buy
+10,647
New +$106K ﹤0.01% 1061
2023
Q4
Sell
-164,282
Closed -$2.03M 1148
2023
Q3
$2.03M Sell
164,282
-64,945
-28% -$662K 0.02% 422
2023
Q2
$2.07M Sell
229,227
-108,690
-32% -$656K 0.02% 433
2023
Q1
$1.17M Sell
337,917
-188,896
-36% -$771K 0.01% 545
2022
Q4
$1.29M Buy
+526,813
New +$1.54M 0.01% 514

Other funds holding OLMA

Vontobel Holding's OLMA Position: Q1 2025 in Review

Vontobel Holding sold out of Olema Pharmaceuticals (OLMA) in Q1 2025, closing a stake of 10,647 shares — an estimated $62.1K sold.

Vontobel Holding first reported a position in OLMA in Q4 2022 and held it in 5 quarters. The position peaked at $2.07M in Q2 2023. 133 funds tracked by Wall St. Rank hold OLMA as of Q1 2025.

  • Vontobel Holding reported no remaining Olema Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 10,647 Olema Pharmaceuticals shares in Q1 2025, an estimated $62.1K.
  • Vontobel Holding first reported a position in Olema Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Vontobel Holding's Olema Pharmaceuticals position peaked at $2.07M in Q2 2023.
  • 133 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.